NanoViricides Inc. (NNVC)
NanoViricides Inc. (NNVC) is a biotechnology company focused on developing nanotechnology-based antiviral drugs. The company's approach involves designing targeted nanomedicines to neutralize viruses and treat viral infections, including emerging and persistent viral threats. NanoViricides aims to create broad-spectrum antivirals that can address a wide range of viral diseases.
Company News
Gainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares surged 109.2% to $7.30 in pre-market trading after gaining 9% on Monday. Better Therapeutics, Inc. (NASDAQ: BTTX) shares gained 51.1% to $1.36 in pre-market trading after the FDA approved the company's AspyreRx prescription-only digital therapeutic treatment to provide cognitive behavio...
SHELTON, Conn., May 04, 2023 (GLOBE NEWSWIRE) -- (via IBN) -- NanoViricides, Inc. (NYSE American: NNVC) (the “Company”), a clinical stage global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, announces that Anil R. Diwan, Ph.D., President of the Company will be presenting at The I...
10 monkeypox stocks and monkeypox penny stocks to watch The post 10 Top Monkeypox Stocks To Watch Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.